Surface Oncology, Inc. is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Email Newsletter: dexwirenews.com/sign-up/
2) Text Message Notifications: dexwirenews.com/sms-newsletter/
3) Telegram: t.me/DEXWireNews
4) Follow Us on our Social Networks
1) Email Newsletter: dexwirenews.com/sign-up/
2) Text Message Notifications: dexwirenews.com/sms-newsletter/
3) Telegram: t.me/DEXWireNews
4) Follow Us on our Social Networks